沉默的呼吸道粘液塞在COPD和临床影响
Sofia K Mettler1, Hrudaya P Nath2, Scott Grumley2
1Department of Medicine, Mount Auburn Hospital, Cambridge, MA; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Chest
|November 28, 2023
概括
沉默的粘液塞在没有症状的COPD患者中很常见. 这些在CT扫描上的插头表明疾病严重程度更差,包括肺功能减弱和恶化风险增加.
科学领域:
- 肺部医学 肺部医学
- 放射学 放射学是一门学科.
- 慢性阻塞性肺病 (COPD) 研究研究
背景情况:
- 呼吸道粘液塞在COPD患者的CT扫描中经常被观察到,即使没有典型的症状,如咳或.
- 这些"沉默的粘液塞"代表了COPD潜在的未被认可的方面.
研究的目的:
- 在COPD患者中确定无声粘液塞的风险和保护因素.
- 调查静音粘液塞和COPD严重程度的各种措施之间的关联.
主要方法:
- 分析了4,363名COPDGene研究参与者的胸部CT扫描.
- 计算出一个粘液塞得分 (0-18段). 使用多变量回归模型确定了风险因素和关联.
主要成果:
- 在1739名无症状的COPD参与者中,36%的人有无声粘液塞.
- 高龄,女性性别和黑人种族是无声粘液塞的危险因素.
- 沉默的粘液塞与较差的6分钟步行距离,较低的氧气和,降低FEV1,增加肺气,更厚的呼吸道和更高的恶化风险相关.
结论:
- 沉默的粘液塞在缺乏典型症状的COPD患者中很普遍.
- 沉默的粘液塞的存在与COPD的功能,结构和临床结果较差有关.
- 通过CT识别的粘液塞可以提高COPD患者的评估和风险分层.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Pathogenesis and Clinical Features
292
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
292
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
214
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
214


